Matic

The platform is the model layer rather than a product with AI added to it. Ambient capture, note generation, coding recommendations, summarisation across fragmented records, decision support and workflow routing are all model output running on what the company describes as a multi agent architecture. It is not an EHR with an AI feature, which is what draws the centrality C treatment elsewhere in this category; it is intelligence sold to sit inside somebody else's EHR or alongside one. No human scribe tier or services layer was found.

A review gate is consistently implied across the materials, with notes described as ready to sign and send and as ready to close, and coding presented as recommendation, recommending the right CPT, ICD-10 and evaluation and management codes based on what happened during the visit rather than assigning them. That is the safer framing this index credits. Held at B rather than A because nothing is published about what happens at the edges: no confidence threshold, no abstention behaviour, no escalation path, and no statement of which outputs require sign off versus which flow onward automatically. That matters more than usual here because the platform reaches well past documentation into revenue cycle, inbox management and follow up, so the number of places where model output can move without a person looking at it is larger than for a pure scribe.

The architecture labels are present but thin, and the numbers actively undermine confidence. Multi agent system, multimodal input and adaptive templates are feature bullets rather than technical disclosure, and no model card, named model, evaluation methodology or error analysis exists. The accuracy figure is given as 99 percent on the platform page and 98 percent on the Scribematic page, which cannot both be right, and neither carries a denominator, comparator or definition of what counts as an error. The claim of 100 percent same day chart closure is the sort of absolute this index flags on the accuracy overclaim watchlist, since a rate of exactly 100 percent across any real population is not a measurement. Support for more than 90 languages is asserted with no per language performance disclosure.

The strongest evidence position in the long tail of this wave, though it stops short of clinical outcome data. KLAS Research has published a report specifically on Scribematic, which is assessment by a competent independent party with a real methodology, and it is the kind of external scrutiny this index credits, on the same basis that a competitive government evaluation earned Knowtex a B. Precision matters here and the record states it plainly: this is a KLAS REPORT, not a Best in KLAS award, and this index has already had to separate those two things for other vendors. A named customer also exists, Catalyst Health Group, with its Dr Christopher Crow appearing in a published spotlight, which is more than a testimonial. Held at B because no peer reviewed study, controlled evaluation or published outcome dataset exists, the KLAS report sits behind KLAS's own access gate, and the logo wall carrying Mayo Clinic, Epic, athenahealth and Privia does not state which of those are customers and which are integrations or platform relationships. Ask which is which.

Named controls and a public place to inspect them, which puts this above most of the lane. AES-256 encryption in transit and at rest, multi factor authentication, role based access controls, and independent third party audits, all set out and reachable through a live trust centre rather than asserted on a marketing page. One deployment option is materially relevant to this axis: when sold as embedded intelligence to an EHR platform, the company states that data and control stay in platform, which for that route means patient content does not accumulate in a separate vendor estate at all. Held at B because the three questions this axis exists to answer are not addressed anywhere located: whether audio is retained and for how long, whether it is deleted after note generation, and whether customer content is used to train models. Encryption is not a retention policy.

HIPAA compliance is claimed and carried through to a trust centre, alongside CCPA, GDPR and PIPEDA, which is a four regime claim consistent with selling across the United States, Europe and Canada. That breadth is more precise than the single regime assertion typical here. Held at B because no business associate agreement terms, availability or tier gating are published, and because a buyer purchasing through the embedded EHR route needs to establish where the BAA chain actually runs, since the contracting party may be the EHR vendor rather than Matic.

The strongest position on this axis found anywhere in this sourcing wave. Both SOC 2 and ISO 27001:2022 are claimed as certified, with the ISO version year stated rather than left vague, and the controls are described concretely: continuous monitoring, regular third party security audits, AES-256 encryption in transit and at rest, multi factor authentication and role based access. Critically, there is a LIVE PUBLIC TRUST CENTRE at a dedicated subdomain, which is the artifact a health system security review actually wants and which almost nothing else in this category maintains. This is also the clean contrast to the watchlist phrasing this index tracks elsewhere: RXNT graded C for hosting in certified data centres, Tripletime C for using certified providers, DeepCura for being SOC 2 aligned. Matic claims the certifications for itself. One precision to confirm rather than assume: SOC 2 is an attestation rather than a certification, and Type I and Type II are very different assurances, so ask which report exists and request the current one under NDA.

Not a regulated medical device and none claimed. The platform does carry a decision support layer described as delivering research backed answers in workflow and transforming patient data into real time insights supporting clinical decisions, which places it on this index's software as a medical device watchlist alongside Avo, Sully, Cleo and others. The evidence grounding claim, that answers are backed by real research, points toward the guideline traceable pattern that this index treats more favourably than opaque inference, but no sources, citation behaviour or scoping analysis were published to confirm it.

Mixed, with the coding language doing the damage. Intelligent coding is summarised as capturing REVENUE AT THE SOURCE, and the platform sells revenue cycle intelligence built on making every visit translate into clean claims, which is capture intensity framing of the kind this index tracks across the coding gradient, and the platform position makes it structural rather than rhetorical: documentation, coding and claim all sit inside one system with no vendor boundary between them, the same architecture that put OmniMD at C. Two genuine counterweights belong alongside it. The phrase used for the outcome is FAIR reimbursement rather than maximised or optimised, which is notably more measured than most of this gradient. And codes are framed as recommended from what actually happened during the visit, which is the defensible framing. Against all of it, no fairness statement, subgroup analysis, accent or dialect performance breakdown or model limitations document was located, and support for more than 90 languages makes that absence consequential rather than academic.

Two claims sit side by side and only one of them is strong. The weaker is EHR agnostic, works across any system, which is the universality phrasing this index treats as a warning sign because in this lane it usually indicates transfer rather than integration. The stronger is a described and distinct product line: Matic sells EMBEDDED INTELLIGENCE to EHR platforms, delivered through the EHR rather than around it, explicitly embedded not bolted on, running inside the platform's own workflows with data and control retained in platform and no rebuild required. That is a real architecture and the deepest possible form of integration, because the scribe becomes part of the record system rather than a visitor to it. Held at B rather than A because the site does not say which of the displayed logos, athenahealth, Epic, Mayo Clinic, Privia, UrgentIQ, ChartPath, Lacenta and CHG, represent shipped embedded integrations as opposed to customers or prospects, and no API, standard or connector is named anywhere. Establish which route applies to your system.

Unusually broad platform coverage plus one genuinely differentiated option. The product runs on Windows, macOS, iOS, Android, web, desktop, mobile and tablet, which is wider than almost anything in this lane and means a clinician moving between workstation, ward and phone stays in one system. The differentiated option is the embedded route, where the company states data and control stay IN PLATFORM, meaning for that deployment patient content remains inside the EHR vendor's environment rather than moving into Matic's. That is a real answer to this index's standing question about where the data goes. Held at B rather than A because no hosting region, residency guarantee, sub processor list or on premise path is published for the direct deployments, and because compliance claims spanning GDPR, PIPEDA and CCPA imply multi region operation without stating where anything actually sits.

Not assessed. No price, unit of pricing, tier structure or trial is published for any of the three buying routes, and every path leads to a booked demo. This follows the house convention of leaving the axis unrated rather than inventing a grade from an absence. Worth noting that a platform sold simultaneously to physician groups, to independent clinicians and to EHR vendors as embedded technology will have three quite different commercial structures, and none of them is described.

Broad and adaptive rather than deep in any one place. Documentation is described as specialty tuned with templates that apply specialty specific formats automatically and adapt by both specialty and individual provider, with consistent output across sites, which is the requirement for a multi site physician group. Settings named span clinic, hospital and on the go, and the customer and partner signals point at primary care through Catalyst Health Group, urgent care through UrgentIQ and post acute through ChartPath. More than 90 languages is among the higher counts in this index. Held at B because no specialty count is given, no clinical instrument, form or scoring system is named anywhere, and on this index's test naming the instrument is what separates genuine domain work from a specialty tuned template library.